FOS and bone neoplasm: Transgenic mice expressing c‐fos under the control of the ubiquitously expressed H2kb promoter (H2‐c‐fosLTR) develop bone tumors with 100% penetrance (Ruther et al, 1989; Grigoriadis et al, 1993).